治疗前影像组学特征预测头颈癌患者个体化淋巴结失败
本研究开发并验证了一种基于治疗前影像组学的预测模型,用于识别头颈鳞癌根治性放疗后存在失败风险的病理性淋巴结。训练集165例患者558个淋巴结,验证集112例患者467个淋巴结。多变量分析确定三个临床特征和两个影像组学特征为独立预后因素,验证集c-index为0.80,高风险组2年淋巴结失败风险阈值60%和低风险组10%对应的阳性和阴性预测值分别为94.4%和98.7%。
要点
- 治疗前CT影像组学联合临床特征可预测个体淋巴结失败风险。
- 验证集c-index达0.80,优于单独临床或影像组学模型。
- 高风险组2年失败风险阈值60%,阳性预测值94.4%。
核心结论
- 治疗前预测模型整合个体淋巴结定量影像组学特征与常用临床特征,可在治疗前识别高失败风险淋巴结。
研究设计与样本
- 训练集165例患者558个病理性淋巴结,验证集112例患者467个病理性淋巴结,均为根治性放疗(联合或不联合系统治疗)的头颈鳞癌患者。
主要发现
- 训练集和验证集分别发生68和23个淋巴结失败。
- 多变量分析显示三个临床特征(T分期、性别、WHO体能状态)和两个影像组学特征(代表淋巴结大小的最短轴长度、代表淋巴结异质性的灰度共生矩阵相关性)为独立预后因素。
关键数值与推荐
- 以估计的2年淋巴结失败风险阈值60%和10%定义高、低风险组,阳性和阴性预测值分别为94.4%和98.7%。
临床怎么用
- 该模型可用于治疗前识别高失败风险淋巴结,可能有助于选择针对个体淋巴结的强化治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To develop and validate a pre-treatment radiomics-based prediction model to identify pathological lymph nodes (pLNs) at risk of failures after definitive radiotherapy in head and neck squamous cell carcinoma patients. MATERIALS AND METHODS: Training and validation cohorts consisted of 165 patients with 558 pLNs and 112 patients with 467 pLNs, respectively. All patients were primarily treated with definitive radiotherapy, with or without systemic treatment. The endpoint was the cumulative incidence of nodal failure. For each pLN, 82 pre-treatment CT radiomic features and 7 clinical features were included in the Cox proportional-hazard analysis. RESULTS: There were 68 and 23 nodal failures in the training and validation cohorts, respectively. Multivariable analysis revealed three clinical features (T-stage, gender and WHO Performance-status) and two radiomic features (Least-axis-length representing nodal size and gray level co-occurrence matrix based - Correlation representing nodal heterogeneity) as independent prognostic factors. The model showed good discrimination with a c-index of 0.80 (0.69-0.91) in the validation cohort, significantly better than models based on clinical features (p < 0.001) or radiomics (p = 0.003) alone. High- and low-risk groups were defined by using thresholds of estimated nodal failure risks at 2-year of 60% and 10%, resulting in positive and negative predictive values of 94.4% and 98.7%, respectively. CONCLUSION: A pre-treatment prediction model was developed and validated, integrating the quantitative radiomic features of individual lymph nodes with generally used clinical features. Using this prediction model, lymph nodes with a high failure risk can be identified prior to treatment, which might be used to select patients for intensified treatment strategies targeted on individual lymph nodes.
引用
- Zhai TT, Langendijk JA, van Dijk LV, et al. Pre-treatment radiomic features predict individual lymph node failure for head and neck cancer patients. Radiother Oncol. 2020. PMID: 32114267. doi:10.1016/j.radonc.2020.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。